MariMed Inc (MRMD)
OTHER OTC:MRMD
Holding MRMD?
Track your performance easily

MariMed (MRMD) Income Statement

421 Followers

MariMed Income Statement

Last quarter (Q2 2024), MariMed's total revenue was $40.44M, an increase of 17.62% from the same quarter last year. In Q2, MariMed's net income was $73.00K. See MariMed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 153.69M$ 148.60M$ 134.01M$ 121.46M$ 50.90M$ 45.60M
Cost of Revenue
$ 87.09M$ 82.68M$ 70.05M$ -55.20M$ 19.57M$ 26.90M
Gross Profit
$ 66.59M$ 65.92M$ 63.96M$ 66.26M$ 31.32M$ 18.70M
Operating Expense
$ 56.78M$ 51.53M$ 43.59M$ -39.40M$ 15.81M$ 13.03M
Operating Income
$ 29.96M$ 14.38M$ 20.37M$ 26.86M$ 15.51M$ 5.67M
Net Non Operating Interest Income Expense
$ -6.56M$ -8.91M$ -734.00K$ -2.25M$ -9.65M$ -12.25M
Other Income Expense
$ 706.00K$ -12.88M$ 127.00K$ 797.38K$ -1.36M$ -75.23M
Pretax Income
$ 830.00K$ -6.60M$ 19.51M$ 23.82M$ 4.50M$ -81.81M
Tax Provision
$ 8.96M$ 9.41M$ 5.90M$ 16.19M$ 2.07M$ 67.16K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.44M$ -16.03M$ 13.46M$ 7.22M$ 2.14M$ -81.18M
Basic EPS
$ -0.01$ -0.04$ 0.04$ 0.02$ 0.01$ -0.39
Diluted EPS
$ -0.01$ -0.04$ 0.04$ 0.02$ 0.01$ -0.39
Basic Average Shares
$ 1.49B$ 363.40M$ 337.70M$ 326.47M$ 266.98M$ 208.72M
Diluted Average Shares
$ 1.49B$ 363.40M$ 380.29M$ 372.40M$ 324.16M$ 208.72M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 143.87M$ 134.21M$ 113.64M$ -94.60M$ 35.38M$ 39.93M
Net Income From Continuing And Discontinued Operation
$ -8.17M$ -16.03M$ 13.47M$ 7.22M$ 2.14M$ -81.18M
Normalized Income
$ 21.43M-$ 80.41M-$ 3.12M$ -46.26M
Interest Expense
----$ 9.81M$ 12.72M
EBIT
$ 9.38M$ 2.59M$ 19.46M$ 26.07M$ 14.31M$ -69.09M
EBITDA
$ 21.08M$ 14.25M$ 30.48M$ 43.84M$ 16.49M$ -67.90M
Currency in USD

MariMed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis